A simple urine and vaginal fluid test developed by Manchester researchers could help identify women at higher risk of womb cancer, while sparing others immediate invasive tests. Read more in The Guardian: https://ow.ly/cqVX50ZWeMU

UK doctors develop non-invasive test for womb cancer in women bleeding after menopause

Test using urine and vaginal fluid samples raises hopes thousands of lower-risk women could be spared internal ultrasounds and hysteroscopies

ow.ly

Could breast milk hold clues that help detect breast cancer earlier? Manchester researchers are recruiting breastfeeding women to the pioneering BRACELET-BM study, which is exploring whether breast milk could offer a new way to detect the disease during or after pregnancy: https://ow.ly/Y8CG50ZW0eF

Scientists study breast milk as an early detection tool for breast cancer - Manchester Cancer Research Centre

A pioneering new study taking place in Manchester is investigating whether breast milk could help detect breast cancer earlier than a blood test or a scan. The research, funded by The Christie Charity and led by scientists at The University of Manchester, aims to transform how doctors detect breast cancer that develops during or just after pregnancy, which is often discovered late when the cancer has already spread, leading to poorer survival rates.

ow.ly

Applications are now open for our 2027 entry @cancerresearchuk.org (CRUK)-funded PhD opportunities! 🧪 👩‍🔬 Interested in applying for a Clinical or Non-Clinical PhD? Explore our available projects: www.crukcentre.manchester.ac.uk/study/resear... 📆 Deadline: Monday 23rd November 2026

The @mcrcnews.bsky.social clinical & non-clinical PhDs are out - come and join us - there are some great projects for all interests. Lots of clinical projects for you budding researchers! @rcradiologists.bsky.social 👇🏽 www.crukcentre.manchester.ac.uk/study/resear...

Research Opportunities - Cancer Research UK Manchester Centre

Explore the range of postgraduate cancer research opportunities available in Manchester.

crukcentre.manchester.ac.uk

New research presented at #ASTRO2026 suggests radio-resistance in muscle-invasive bladder cancer can evolve during treatment. Professor Ananya Choudhury (@achoud72.bsky.social) highlighted potential biomarkers that could support more personalised radiotherapy. www.urotoday.com/conference-h...

Recent work from the Genome Stability Lab was published in Nature Communications over the summer 👉 www.nature.com/articles/s41... Using systematic screening, photo-crosslinking, high-resolution NMR, and cellular biochemistry, we uncover a UFM1 signalling module in genome stability 🧬

Join us for the next MCRC 20th Anniversary Seminar Series event with Prof Richard Sullivan, exploring cancer care in times of conflict, global health security and resilient health systems. 📅 10 Nov 2026, 15:00–16:30 📍 Schuster Building, Manchester 🎟️ Register: https://ow.ly/POFV50ZFEwQ

Join @cruk-cityoflondon.bsky.social this month for the next 'Let’s Talk About..' online webinar on 'Being Technical Staff – The Highs, Lows and Surprises' on Friday 25 September 2026. Find out more and register ➡️ zurl.co/Qvn0M @mcrcnews.bsky.social

A simple tear-fluid test could one day help detect brain tumours earlier. 💧 Prof Petra Hamerlik from The University of Manchester is leading an NHS-approved study, inspired by the loss of her father to a brain tumour when she was 15. www.bbc.co.uk/news/article...

Dad's death inspired my cancer research, says scientist

Prof Petra Hamerlik is leading a study using tear fluid to test for brain tumours at the University of Manchester.

bbc.co.uk

Applications are open for a fully funded 3-year ACED PhD Studentship, offering UK Home-rate fees, an annual stipend and UK/US multi-centre training. 📅 Deadline: 12th October Apply: https://www.crukcentre.manchester.ac.uk/aced/funding-opportunities/

Funding Opportunities - Cancer Research UK Manchester Centre

crukcentre.manchester.ac.uk

Join us for a seminar from Prof Linda Mileshkin: “Advancing Cancer Care through Early Drug Development at Peter Mac”. 📅 11 Sep, 14:00–15:00 📍OCRB Lecture Theatre Hear insights from Professor Mileshkin’s work in medical oncology, clinical trials & gynaecological cancers. https://ow.ly/7MRe50ZKAvW

Join Prof Richard Sullivan for a timely MCRC 20th Anniversary Seminar on cancer care in conflict, global health security and building resilient systems when they’re needed most. 📅 10 Nov, 15:00–16:30 📍 Schuster Building, Manchester 🎟️ Register: https://ow.ly/3yB150ZFEtz

What does a day in the life of a PhD student at the MCRC look like? 👩‍🔬 Meet Sewa, a third-year PhD student in our Targeted Therapy Group, whose research explores how radiotherapy affects immune cells and their ability to fight cancer cells. 📽️ https://www.youtube.com/watch?v=5uI2S8naxp8

Join us for an MCRC Welcome Lecture with Professor Ludwig Dubois, Chair in Experimental and Translational Radiobiology at The University of Manchester. 📅 Thursdat 10 September 🕓 16:00–17:00 📍Oglesby Cancer Research Building Register: https://ow.ly/PX5g50ZCrkj

MCRC Welcome Lecture – Professor Ludwig Dubois

‘Combination strategies within radiobiology – past and future directions’

ow.ly

🎓 Massive congratulations to our fantastic Medical Oncology honorary consultant colleagues at The Christie NHS Foundation Trust on their promotions to 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗖𝗵𝗮𝗶𝗿𝘀 @manchester.ac.uk! 🌟Prof Sacha Howell 🌟Prof Natalie Cook 🌟Prof Colin Lindsay @uom-dcs.bsky.social @mcrcnews.bsky.social

Could a new trial drug help make blood cancer treatment safer? Researchers in Manchester are investigating whether it could protect healthy blood cells during treatment - helping to reduce infections, fatigue and delays to care. https://ow.ly/mxPO50ZCqFI

Trial drug could reduce side-effects of blood cancer treatments - Manchester Cancer Research Centre

A UK-led clinical trial is set to test a new drug that could make cutting-edge cancer treatments safer and more accessible for thousands of patients with multiple myeloma, a type of blood cancer.

ow.ly

Applications are now open for a fully funded 3-year ACED PhD Studentship in cancer early detection. Includes: 🇬🇧 UK Home-rate fees covered 🔬 UK/US multi-centre training 📅 Deadline: 12th October Apply: https://www.crukcentre.manchester.ac.uk/aced/funding-opportunities/

Funding Opportunities - Cancer Research UK Manchester Centre

crukcentre.manchester.ac.uk

How can we better identify cervical cancers that are more likely to resist treatment? A new paper developed and validated a 55-gene hypoxia signature, showing it can identify tumours linked to poorer outcomes across independent patient cohorts. Read more: www.sciencedirect.com/science/arti...

Hypoxia-associated gene signature for uterine cervical cancer

Tumour hypoxia is associated with treatment resistance and adverse outcome in cervical cancer, but clinically robust methods for hypoxia stratificatio…

sciencedirect.com

🧠 How can #engineering new models of the human brain help us understand #BrainCancer? Join our next #ConvergingOnCancer International Seminar 📅3 September, 10-11am BST

How can combining radiotherapy with other treatments improve outcomes for people with cancer? Join us for an MCRC Welcome Lecture with Professor Ludwig Dubois, Chair in Experimental & Translational Radiobiology at The University of Manchester 📅 10 Sep, 16:00–17:00 📍OCRB https://ow.ly/ifW550Zz1qh

A trial drug could help reduce side effects from blood cancer treatment. Researchers in Manchester are exploring whether the treatment can protect healthy blood cells, helping patients avoid infections, fatigue and delays to care. https://ow.ly/Cc9m50Zz1K0

Trial drug could reduce side-effects of blood cancer treatments - Manchester Cancer Research Centre

A UK-led clinical trial is set to test a new drug that could make cutting-edge cancer treatments safer and more accessible for thousands of patients with multiple myeloma, a type of blood cancer.

ow.ly

Scientists have identified two short windows after glioblastoma surgery when treatment could be delivered more effectively. The early-stage findings could help reshape care for one of the most aggressive forms of brain cancer. Read more in The Independent: https://ow.ly/W6hz50Zy0CE

Manchester researchers have developed a blood test to help doctors monitor advanced melanoma treatment in real time. By tracking circulating tumour DNA in the blood, the test could help identify whether treatment is working or needs to change weeks earlier than scans: https://ow.ly/TUvQ50ZwZz4

Join @cruk-cityoflondon.bsky.social for the next 'Let’s Talk About..' online webinar on 'Being Technical Staff – The Highs, Lows and Surprises' on Friday 25 September 2026. Find out more and register ➡️ zurl.co/Qvn0M @mcrcnews.bsky.social

Looking for your next step in cancer research? 👩‍🔬🧬 Each year, we offers a range of funded PhD projects, including clinical, non-clinical & MB-PhD opportunities. Complete our short form to be the first to know when projects open: https://www.crukcentre.manchester.ac.uk/study/research-opportunities/

Research Opportunities - Cancer Research UK Manchester Centre

Explore the range of postgraduate cancer research opportunities available in Manchester.

crukcentre.manchester.ac.uk

As an early-phase trialist, I never stop being amazed by the bravery & generosity of people who step forward into the unknown. Patients like Tracy don't just shape their own care; they open doors for everyone who follows. 🔬 So it means a great deal to share a 𝗴𝗹𝗼𝗯𝗮𝗹 𝗳𝗶𝗿𝘀𝘁 🌎... @mcrcnews.bsky.social

Oldham woman becomes world's first to receive new cancer therapy

Tracy Tomlinson was offered the clinical trial for ovarian cancer at The Christie hospital in Manchester.

bbc.co.uk

Conferences can be a powerful way for early-career researchers to discover new ideas, build confidence & connect with the wider cancer research community. SciComms Ambassador Florentia Mousoullou shares her reflections & stand out moments from EACR 2026: https://ow.ly/Ks6050ZoVGT

Inside EACR 2026: A PhD Student’s View from Europe’s Leading Cancer Research Congress - Manchester Cancer Research Centre

In June 2026, I travelled to Budapest, Hungary, to attend the European Association for Cancer Research Congress. As one of Europe’s leading cancer research meetings, EACR brings together thousands of scientists working across basic, preclinical and translational cancer research.

ow.ly

Congratulations to everyone who graduated from the Faculty of Biology, Medicine and Health last week! 🎓 After years of hard work, you’ve reached an incredible milestone – and we can’t wait to see what you do next. Here’s some advice from our 2026 graduates...

From delegate to speaker 🎤 Cancer Sciences PhD student & SciComms Ambassador Florentia Mousoullou reflects on presenting her research at IPSCC 2026 in Amsterdam & the value of student-led conferences for early career researchers. https://ow.ly/lba950ZoWj1

Follow Sewa, a third-year PhD student in our Targeted Therapy Group. From lab work to advice for future students, Sewa offers a glimpse into life as a non-clinical PhD student in Manchester: https://www.youtube.com/watch?v=5uI2S8naxp8

Day In The Life as a Cancer Sciences PhD student

In this video Adesewa takes us through her typical day, including taking us on a tour of her lab facilities and carrying out experiments, as well as her advice to students thinking of doing a PhD in Manchester.

youtube.com